The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
Open accessAbstract
Despite great progress in curing childhood acute lymphoblastic leukemia (ALL), survival after relapse remains poor. We analyzed survival after relapse among 9585 pediatric patients enrolled on Children's Oncology Group clinical trials between 1988 and 2002. A total of 1961 patients (20.5%) experienced relapse at any site. The primary end point was survival. Patients were subcategorized by the site of relapse and timing of relapse from initial diagnosis. Time to relapse remains the strongest predictor of survival. Patients experiencing early relapse less than 18 months from initial diagnosis had a particularly poor outcome with a 5-year survival estimate of 21.0±1.8%. Standard risk patients who relapsed had improved survival compared with their higher risk counterparts; differences in survival for the two risk groups was most pronounced for patients relapsing after 18 months. Adjusting for both time and relapse site, multivariate analysis showed that age (10+ years) and the presence of central nervous system disease at diagnosis, male gender, and T-cell disease were significant predictors of inferior post-relapse survival. It can be noted that there was no difference in survival rates for relapsed patients in earlier vs later era trials. New therapeutic strategies are urgently needed for children with relapsed ALL and efforts should focus on discovering the biological pathways that mediate drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., Smigal, C., & Thun, M. J. (2006) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.2.106 · Cited by 5,314
Treatment of Acute Lymphoblastic Leukemia
Pui, C.-H., & Evans, W. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052603 · Cited by 1,976
Smith, M., Arthur, D., Camitta, B., Carroll, A. J., Crist, W., Gaynon, P., Gelber, R., Heerema, N., Korn, E. L., Link, M., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.18 · Cited by 901
Self-citationBhatia, S., Yasui, Y., Robison, L. L., Birch, J. M., Bogue, M. K., Diller, L., DeLaat, C., Fossati-Bellani, F., Morgan, E., Oberlin, O., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.059 · Cited by 613
Mattano, L. A., Sather, H. N., Trigg, M. E., & Nachman, J. B. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.18.3262 · Cited by 399
Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995
Gaynon, P., Trigg, M., Heerema, N., Sensel, M., Sather, H., Hammond, G., & Bleyer, W. (2000) · Leukemia · doi:10.1038/sj.leu.2401939 · Cited by 319
Self-citationThe national cancer data base report on patterns of childhood cancers in the United States
Grovas, A., Fremgen, A., Rauck, A., Ruymann, F. B., Hutchinson, C. L., Winchester, D. P., & Menck, H. R. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971215)80:12<2321::aid-cncr14>3.0.co;2-w · Cited by 216
Fifty Years of Studies of the Biology and Therapy of Childhood Leukemia
Kersey, J. H. (1997) · Blood · doi:10.1182/blood.v90.11.4243.4243_4243_4251 · Cited by 180
Long‐term follow‐up of relapsed childhood acute lymphoblastic leukaemia
Chessells, J. M., Veys, P. A., Kempski, H. M., et al. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04584.x · Cited by 155
Barredo, J. C., Devidas, M., Lauer, S. J., Billett, A. L., Marymont, M. H., Pullen, J., Camitta, B. M., Winick, N. J., Carroll, W. L., & Ritchey, A. K. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3373 · Cited by 112
Self-citationBone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia
Rivera, G. K., Zhou, Y., Hancock, M. L., Gajjar, A. J., Rubnitz, J. E., Ribeiro, R. C., Sandlund, J. T., Hudson, M. M., Relling, M. V., Evans, W. E., et al. (2004) · Cancer · doi:10.1002/cncr.20743 · Cited by 82
Risk of Adverse Events After Completion of Therapy for Childhood Acute Lymphoblastic Leukemia
Pui, C., Pei, D., Sandlund, J. T., Campana, D., Ribeiro, R. C., Razzouk, B. I., Rubnitz, J. E., Howard, S. C., Hijiya, N., Jeha, S., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.0033 · Cited by 75
TEL Deletion Analysis Supports a Novel View of Relapse in Childhood Acute Lymphoblastic Leukemia
Zuna, J., Ford, A. M., Peham, M., Patel, N. R., Saha, V., Eckert, C., Köchling, J., Panzer‐Grümayer, R., Trka, J., & Greaves, M. F. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0584 · Cited by 70
Wofford, M. M., Smith, S. D., Shuster, J. J., et al. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.4.624 · Cited by 59
Hutchinson, R. J., Gaynon, P. S., Sather, H. N., Bertolone, S. J., Cooper, H., Tannous, R., Wells, L. M., Heerema, N. A., Sailer, S. L., & Trigg, M. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.009 · Cited by 57
Self-citation
Cited by
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Acute Lymphoblastic Leukemia in Children
Hunger, S. P., & Mullighan, C. G. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1400972 · Cited by 2,204
Self-citationFry, T. J., Shah, N. N., Orentas, R. J., Stetler-Stevenson, M., Yuan, C. M., Ramakrishna, S., Wolters, P., Martin, S., Delbrook, C., Yates, B., et al. (2018) · Nature Medicine · doi:10.1038/nm.4441 · Cited by 1,335
Hunger, S. P., Lu, X., Devidas, M., Camitta, B. M., Gaynon, P. S., Winick, N. J., Reaman, G. H., & Carroll, W. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8018 · Cited by 1,180
Self-citationCD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
Maude, S. L., Teachey, D. T., Porter, D. L., & Grupp, S. A. (2015) · Blood · doi:10.1182/blood-2014-12-580068 · Cited by 727
Metadata
- Authors
- Nguyen, K., Devidas, M., Cheng, S.-C., La, M., Raetz, E. A., Carroll, W. L., Winick, N. J., Hunger, S. P., Gaynon, P. S., Loh, M. L., & for the Children's Oncology Group
- Venue
- Leukemia
- Published
- 2008-09-25
- Volume
- 22
- Issue
- 12
- Pages
- 2142-2150
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W1987446594
- Cited by
- 582
- References
- 18
- FWCI
- 16.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.